20/20 Biolabs, Inc.
About 20/20 Biolabs, Inc.
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $2.0M
- Net income
- -$3.7M
- Total assets
- $4.1M
- Market cap
- $8.5M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $8.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 19, 2026
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review 20/20 Biolabs, Inc..
